Fulgent Genetics Inc (FLGT) — Cash Flow Reinvestment Rate
Fulgent Genetics Inc (FLGT) has a Cash Flow Reinvestment Rate of 10.84x as of March 2026, reinvesting $76.90 Million (capex $5.20 Million plus investments $71.70 Million) from operating cash flow of $7.10 Million. See cash generation quality of Fulgent Genetics Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Fulgent Genetics Inc Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Fulgent Genetics Inc across 8 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Fulgent Genetics Inc.
Annual Cash Flow Reinvestment Rate for Fulgent Genetics Inc (2016–2024)
Year-by-year capital reinvestment analysis for Fulgent Genetics Inc. See FLGT free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.69x | $98.67 Million | $21.06 Million | $40.31 Million | ▲ +107.0% |
| 2023 | 2.26x | $61.10 Million | $27.00 Million | $22.21 Million | ▲ +104.8% |
| 2022 | 1.10x | $280.09 Million | $253.52 Million | $18.77 Million | ▲ +22.7% |
| 2021 | 0.90x | $484.74 Million | $538.58 Million | $23.84 Million | ▼ -61.2% |
| 2020 | 2.32x | $326.45 Million | $140.63 Million | $36.51 Million | ▼ -55.9% |
| 2019 | 5.26x | $29.05 Million | $5.52 Million | $1.18 Million | ▼ -19.1% |
| 2017 | 6.51x | $8.66 Million | $1.33 Million | $5.36 Million | ▼ -38.5% |
| 2016 | 10.58x | $46.58 Million | $4.41 Million | $3.79 Million | — |